210 likes | 604 Views
SARC Business Meeting. November 2005. Trial Update. SARC 001 Gleevec Closed to accrual Outstanding data Requests SARC 002 STS/gem-txt Closed to accrual Outstanding data Requests. IRB/Contracts Mayo MDAnderson 5 NCI 3 Ortho Hosp Penn Univ of MI 2 Wash Cancer 1 Yale 1.
E N D
SARC Business Meeting November 2005
Trial Update • SARC 001 Gleevec • Closed to accrual • Outstanding data • Requests • SARC 002 STS/gem-txt • Closed to accrual • Outstanding data • Requests
IRB/Contracts Mayo MDAnderson 5 NCI 3 Ortho Hosp Penn Univ of MI 2 Wash Cancer 1 Yale1 Contracts Partners Emory Univ Florida Neither MSKCC Seattle UCLA Univ Toronto Moffitt Trial UpdateSARC 003 bone/gem-txt
Trial UpdateSARC 004 • DFSP/Gleevec • University of Michigan • Seattle • Partners • MSKCC • MDAnderson
SARC 005 Adjuvant uterine/ gem/txt IRB approval pending from MSKCC Contracts Database development GOG SARC 006 MPNST DoD Database development Trial Update
Data capture Web based Ongoing training for data quality CACR Center for the Advancement of Clinical Research Michigan Drug distribution Centralized pharmacy Reputation for quality Biologics North Carolina Trial Support
Location • Rented office space • Dominos Farms 24 Frank Lloyd Wright Dr Ann Arbor, MI
Employees • Administrative assistant • Barb Thibert • Accountant • Keith Locke • Research Project Manager • Emily Hollenberg, RN, MPH
Finances • Income (from inception 11/03) • $505,156 • Expenses (from inception 11/03) • $192,202
Finances • Income (by category) • Biannual meeting $ 15,000 • Donations $ 20,000 • Guideline Translation $ 25,000 • Primary Vascular $ 4,300 • Rosenfeld Symposia $ 50,000 • SARC 002 $ 92,356 • SARC 003 $ 40,000 ($ 78,000) • SARC 004 $ 25,000 • Scientific Symposia $133,500 • Website Development $100,000 $505,156
Finances • Expenses (by category) • Biannual meeting $ 17,871 • Operating expenses $ 49,650 • SARC 002 $ 52,332 • SARC 003 $ 40,229 • Scientific symposia $ 31,942 • Website development $ 180 $192,202
Executive Committee • Monthly calls • Review all trials • Discuss protocols in development
Board of Directors • Annual Meeting • November 18,2005
Development Subcommittee • Members • Deborah Buks • David Marsh • Tim McCormick • Charles Nearberg • Activities • Discuss strategies • Evaluate potential opportunities
David Marsh Eugene and Maxine Rosenfeld
Ann Foote-Primary Vascular Sarcoma Fund Paul Corliss The Silver Fox Club contributes 10 percent of its sales to helping those with sarcoma cancer, which has affected the founder’s wife. Out Fox Sarcoma
Development • Meeting with Dr. Doroshow • Utilize website • RO1 application • Continue to explore additional funding opportunities
Website Development • Proposal from Altum/CommonHealth
Website • Destination for sarcoma clinical trials • Source of information • Physicians • Patients and families • Emphasize credibility • Call to action • Clinical trials • Support • Link with other sites
Guideline Translation • Nancy Leahy • Laura Zyczynski • Jenni Heaton • Joan Giblin • Kelly Scheu • Linda Sohn • Monica Davey • Lauren Long • Donna Bernstein • Terri Armen • Carolyn Hayes • Denise Parker • 7 pending
New Business • Future directions • Developmental therapeutics • Launch website • Maximize • Clinical trial awareness • Education • Outreach • Partnering